Cronos Group Inc. ( CRON) - Stock Earnings
CRON Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -1.8 million USD | 91.3 million USD |
| 2026Q1 | 13.6 million USD | 44.6 million USD |
| 2026Q2 | 32.1 million USD | 70.6 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
CRON Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -74.0 million USD | 87.2 million USD |
| 2024 | 41.1 million USD | 117.6 million USD |
| 2025 | -9.6 million USD | 149.2 million USD |
| 2026 Est. | — | — |
CRON
Price: $3.22
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.20 USD
P/E Ratio: 15.85
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Canada
Volume: 1.5 million
Market Capitalization: 1.2 billion